NCT07104331 2026-03-03
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Sarcoma Alliance for Research through Collaboration
Phase 2 Recruiting
Sarcoma Alliance for Research through Collaboration
St. Jude Children's Research Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
BridGene Biosciences Inc.